Nevro to Present at 10th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

Nevro Corp. (NYSE: NVRO), a leader in chronic pain treatment, announced that D. Keith Grossman, Chairman and CEO, will present at the 10th Annual SVB Leerink Global Healthcare Conference on February 26, 2021, at 10:40 AM ET. A live webcast and archived recording of the presentation will be available on Nevro's website. The company is known for its innovative Senza spinal cord stimulation system, which has shown efficacy in reducing opioid dependency in chronic pain patients.

REDWOOD CITY, Calif., Feb. 1, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the 10^th Annual SVB Leerink Global Healthcare Conference on Friday, February 26, 2021 at 10:40 am Eastern Time / 7:40 am Pacific Time.

A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro's website at www.nevro.com. 

Internet Posting of Information

Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at www.nevro.com.  The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in ≥65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

To learn more about Nevro, connect with us on LinkedIn, Twitter, Facebook and Instagram.

Investors and Media:
Julie Dewey, IRC
Nevro Corp.
Vice President, Investor Relations & Corp Communications
650-433-3247  |  julie.dewey@nevro.com 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/nevro-to-present-at-10th-annual-svb-leerink-global-healthcare-conference-301213970.html

SOURCE Nevro Corp.

FAQ

When is Nevro's presentation at the SVB Leerink Global Healthcare Conference?

Nevro's presentation is scheduled for February 26, 2021, at 10:40 AM ET.

What is Nevro Corp. known for?

Nevro Corp. is known for its innovative solutions in chronic pain treatment, particularly the Senza spinal cord stimulation system.

Where can I watch Nevro's conference presentation?

You can watch the live webcast and access the archived recording on Nevro's website.

What is the stock symbol for Nevro?

The stock symbol for Nevro Corp. is NVRO.

What therapy does Nevro's Senza system deliver?

Nevro's Senza system delivers the proprietary HF10 therapy for chronic pain management.